View of Formulation Development and Pharmacological Evaluation of Curcumin–Resveratrol Co-Loaded Lipid Nanoparticles for Synergistic Protection Against Diabetic Cardiomyopathy in Type 2 Diabetes Mellitus

Return to Article Details Formulation Development and Pharmacological Evaluation of Curcumin–Resveratrol Co-Loaded Lipid Nanoparticles for Synergistic Protection Against Diabetic Cardiomyopathy in Type 2 Diabetes Mellitus Download Download PDF